Whether you are dealing with severe consequences of cystic fibrosis or want to get ahead the symptoms, these tips will help.

Cystic fibrosis is a genetic disease that causes ... However, it does not always eradicate the bacteria responsible for respiratory infections. By studying 3D models of human lung cells ...

Cystic fibrosis pulmonary disease is characterized by chronic and recurrent infection, airway inflammation, bronchiectasis and progressive obstructive lung physiology. Advances in the treatment of ...

Allison Angell, the first person in the UK to have all of her major organs transplanted, has died aged 46—more than a decade ...

BX-004 is under development for the treatment of cystic fibrosis, non-cystic fibrosis bronchiectasis and resistant pseudomonas aeruginosa infections. It is administered as inhalational formulation.

NA: Not available. Cystic fibrosis (CF) pulmonary disease is characterized by chronic and recurrent infection, and airway inflammation. Colonization and chronic airway infection with bacterial ...

The US Food and Drug Administration has approved Alyftrek, a once-daily oral combination of vanzacaftor, tezacaftor, and ...

The Food and Drug Administration (FDA) has approved Alyftrek ™ (vanzacaftor/tezacaftor/deutivacaftor) for the treatment of cystic fibrosis (CF) in patients aged 6 years and olde ...

LOS GATOS, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (OTC: ARDS) (“Aridis” or the “Company”), a biopharmaceutical company, today announced a corporate update on recent ...

Mehdi obtained his MSc Degree in “Molecular Interactions and Therapeutics” from Jules Verne University of Amiens (France). In ...

Cystic fibrosis is a genetic disorder that primarily affects the lungs and pancreas, causing persistent respiratory infections, severe digestive issues, and other complications. Symptoms include ...